The role of pharmacogenetics in making treatment decisions in colorectal cancer Anthony B. El-KhoueiryHeinz Josef Lenz OriginalPaper Pages: 109 - 115
Evidence for resection of colorectal liver metastases Thomas A. AloiaRené AdamDenis Castaing OriginalPaper Pages: 120 - 124
Targeted therapies in colorectal cancer: Complications and management Mark L. SundermeyerStuart R. LessinNeal J. Meropol OriginalPaper Pages: 125 - 133
Oral fluoropyrimidines in the adjuvant therapy of colon cancer R. M. GlasspoolJ. Cassidy OriginalPaper Pages: 137 - 141
Oxaliplatin and irinotecan: From advanced to adjuvant therapy of colon cancer Ki Young ChungLeonard B. Saltz OriginalPaper Pages: 142 - 148
Stratifying risks for patients with localized rectal cancer: Do all stage II patients require adjuvant radiation or chemoradiation? Leonard L. GundersonMatthew CallisterJonathan Efron OriginalPaper Pages: 151 - 159
Sphincter and rectal preservation approaches for early stage distal rectal cancers Jean-Pierre GerardAmir ArefpourEric Francois OriginalPaper Pages: 161 - 167